7.3 Venoarterial ECMO (VA-ECMO) & Differential Hypoxemia

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is the ultimate mechanical rescue modality for refractory biventricular cardiogenic shock and extracorporeal cardiopulmonary resuscitation (E-CPR). By bypassing both the failing heart and the injured lungs, VA-ECMO delivers fully oxygenated, decarboxylated blood under high pressure into the arterial system. However, the fluid mechanics of peripheral VA-ECMO present complex hemodynamic trade-offs. Retrograde aortic flow collides with native left ventricular ejection, increasing left ventricular afterload, promoting intra-alveolar pulmonary hemorrhage, and precipitating differential hypoxemia (Harlequin syndrome).

---

1. Circuit Architecture: Peripheral vs. Central VA-ECMO

Peripheral Venoarterial ECMO (VA-ECMO) Circuit Architecture:

      [ Right Atrium / Vena Cava ]
                   │
                   ▼ Multi-stage Venous Drainage Cannula (21–25 Fr)
       ┌───────────────────────┐
       │   Centrifugal Pump    │ ──> Negative Drainage Pressure (-30 to -80 mmHg)
       └───────────────────────┘
                   │
                   ▼
       ┌───────────────────────┐
       │  Membrane Oxygenator  │ <── Sweep Gas (CO2 Clearance) + Sweep FiO2
       │   & Heat Exchanger    │
       └───────────────────────┘
                   │
                   ▼ Oxygenated Arterial Return (15–19 Fr)
       ┌───────────────────────┴───────────────────────┐
       ▼                                               ▼
[ Femoral Artery ]                             [ Distal Perfusion Catheter ]
(Retrograde Flow to Aorta)                    (Antegrade Flow to Superficial Femoral Artery
                                               Prevents Critical Limb Ischemia)

The Peripheral Cannulation Configuration

1. Venous Drainage: A large multi-stage cannula ($21\text{--}25\text{ Fr}$) is introduced via the femoral vein, with its tip positioned at the cavoatrial junction or within the right atrium under echocardiographic guidance. Blood is drained from the systemic venous circulation under negative pressure generated by the centrifugal pump.
2. Centrifugal Pump & Oxygenator: The pump propels blood through a polymethylpentene (PMP) hollow-fiber membrane oxygenator. Oxygenation is controlled by adjusting the fraction of delivered oxygen ($\text{FdO}_2$ or Sweep $\text{FiO}_2$, typically set at $1.0$), while carbon dioxide clearance is governed by the sweep gas flow rate (liters/min).
3. Arterial Reinfusion: Oxygenated blood is returned into the systemic circulation via a femoral arterial cannula ($15\text{--}19\text{ Fr}$), reinfusing blood retrogradely up the external iliac, common iliac, and abdominal aorta toward the aortic arch.
4. Distal Perfusion Catheter (DPC): Insertion of a large-bore cannula into the common femoral artery significantly impedes distal antegrade blood flow to the lower extremity. Placement of a dedicated $5\text{--}7\text{ Fr}$ antegrade distal perfusion cannula into the superficial femoral artery is mandatory to prevent acute lower limb compartment syndrome, rhabdomyolysis, and limb loss.

Central Cannulation Configuration

In post-cardiotomy patients or those with severe peripheral arterial disease, central cannulation is performed via median sternotomy. The venous drainage cannula is placed in the right atrium, and the arterial return cannula is sewn directly into the ascending aorta. While central cannulation eliminates retrograde flow conflicts and prevents differential hypoxemia, it carries substantial risks of surgical bleeding, mediastinitis, and necessitates re-sternotomy for decannulation.

---

2. Retrograde Flow Mechanics & Left Ventricular Overdistension

In peripheral femoral VA-ECMO, the mechanical pump propels blood upward against the normal direction of aortic blood flow. This creates profound alterations in left ventricular loading conditions:

The Left Ventricular Distension Spiral in Peripheral VA-ECMO:

High Retrograde Arterial Flow ──> Massive Increase in LV Afterload
                                            │
                                            ▼
Failing LV Cannot Overcome Afterload ──> Aortic Valve Remains Closed Throughout Systole
                                            │
                                            ▼
Bronchial & Thebesian Venous Drainage ──> Blood Trapped in Non-Ejecting LV Cavity
                                            │
                                            ▼
Extreme Elevation in LVEDP & PCWP (> 25–35 mmHg) ──> Massive Hydrostatic Pulmonary Edema
                                            │
                                            ▼
Stasis in LV Cavity & Aortic Root ──> Thrombus Formation ("Smoke" / Echocardiographic Sludge)

The Pathophysiology of LV Distension

• Aortic Valve Competence & Stasis: When native myocardial contractility is severely depressed, the LV cannot generate sufficient peak systolic pressure to exceed the high diastolic pressure maintained in the aortic root by the ECMO circuit. The aortic valve fails to open (demonstrated by a flat, non-pulsatile arterial line waveform with pulse pressure $< 10\text{ mmHg}$).
• Volume Accumulation: Even if the ECMO circuit drains venous return, approximately $5\%\text{ to }10\%$ of cardiac output still enters the left heart via bronchial arterial circulation (draining into pulmonary veins) and thebesian myocardial veins (draining directly into the LV cavity). With the aortic valve permanently closed and the mitral valve incompetent from annular dilation, blood becomes trapped in the left ventricle.
• Hydrostatic Pulmonary Edema: LVEDP and PCWP soar to $30\text{--}40\text{ mmHg}$, overwhelming pulmonary capillary oncotic pressure. Patients develop fulminant alveolar flooding, manifesting as copious pink frothy secretions from the endotracheal tube and complete radiographic "white-out" of both lungs.
• Intracardiac Thrombosis: Severe blood stasis within the non-ejecting LV cavity and the closed aortic root promotes rapid stagnation. Spontaneous echocardiographic contrast ("smoke") evolves into massive intraventricular or aortic root thrombi that can embolize or prevent ventricular recovery.

---

3. Left Ventricular Venting Modalities

Active mechanical unloading ("LV venting") is essential whenever a patient on VA-ECMO exhibits loss of arterial pulsatility, elevated PCWP ($> 20\text{--}25\text{ mmHg}$), worsening pulmonary edema, or echocardiographic evidence of LV dilation.

Decompression Modalities Comparison

Evidence Base: ECLS-SHOCK and the ECPR Trials

• ECLS-SHOCK (Thiele et al., NEJM 2023): 420 patients with acute MI-related cardiogenic shock and planned early revascularization were randomized to early VA-ECMO plus usual care or usual care alone. 30-day mortality was 47.8% vs. 49.0% (relative risk 0.98, 95% CI 0.80-1.19), while moderate or severe bleeding (23.4% vs. 9.6%) and peripheral vascular complications needing intervention (11.0% vs. 3.8%) were more frequent with ECMO. Routine early VA-ECMO in AMI-CS is therefore not supported; it remains a rescue option for selected refractory shock.
• ARREST (Yannopoulos et al., Lancet 2020): In 30 patients with refractory out-of-hospital VF arrest, early ECMO-facilitated resuscitation raised survival to discharge from 7% to 43%; the single-center trial stopped early for benefit.
• Prague OHCA (Belohlavek et al., JAMA 2022): In 264 patients with refractory OHCA, an invasive strategy (mechanical CPR, intra-arrest transport, ECPR) did not significantly improve 180-day survival with good neurologic outcome (31.5% vs. 22.0%, $p = 0.09$).
• INCEPTION (Suverein et al., NEJM 2023): In a pragmatic multicenter trial of 134 patients with refractory VF/VT arrest, ECPR did not significantly improve 30-day survival with favorable neurologic outcome (20% vs. 16%).

The common thread is that ECPR helps only in highly selected patients (witnessed arrest, shockable rhythm, short low-flow time) treated in systems that can achieve rapid cannulation; current AHA guidance considers ECPR reasonable for such patients within an appropriately trained and equipped system of care.

4. Harlequin Syndrome (Differential Hypoxemia / North-South Syndrome)

Harlequin syndrome—also designated North-South syndrome or differential hypoxemia—is a unique, life-threatening complication seen exclusively in peripheral femoral VA-ECMO.

Pathophysiologic Mechanism

Differential hypoxemia develops when two distinct clinical phenomena occur simultaneously:

1. Recovery of Native Left Ventricular Function: The myocardium begins to recover (e.g., following revascularization for myocardial infarction, resolution of stun, or myocarditis), regaining the ability to eject forward stroke volume.
2. Persistent, Severe Pulmonary Parenchymal Dysfunction: The patient's lungs remain severely compromised by acute respiratory distress syndrome (ARDS), dense pulmonary contusions, diffuse aspiration, or massive hydrostatic pulmonary edema.

When deoxygenated blood returning to the left heart fails to undergo gas exchange in the damaged lungs, the recovering left ventricle ejects hypoxemic, deoxygenated blood into the ascending aorta.

Simultaneously, the peripheral ECMO circuit returns hyperoxygenated blood retrogradely up the descending thoracic aorta. These two opposing streams of blood collide within the aorta at an interface known as the mixing point or watershed zone:

Harlequin Syndrome Anatomical Vascular Perfusion:

         [ Deoxygenated Ejection from Native LV ]
                          │
                          ▼
     ┌────────────────────┴────────────────────┐
     ▼                                         ▼
Coronary Arteries                    Brachiocephalic Trunk
(Myocardial Hypoxia)                           │
                                      ┌────────┴────────┐
                                      ▼                 ▼
                              Right Carotid      Right Subclavian
                              (Brain Hypoxia)   (Right Arm Cyanosis)

 ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ [ WATERSHED MIXING POINT ] ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~

                          ▲
                          │
    [ Hyperoxygenated Retrograde Flow from Femoral VA-ECMO ]
                          │
     ┌────────────────────┴────────────────────┐
     ▼                                         ▼
Celiac / Mesenteric Arteries           Iliac & Lower Extremities
(Normal / High Saturation)             (Warm, Pink, SaO2 100%)

Clinical Presentation & The Diagnostic Imperative

• The Anatomical Trap: Because the coronary ostia and the brachiocephalic trunk take off proximal to the watershed in the ascending aorta and proximal arch, they receive pure, deoxygenated native cardiac output. Consequently, the heart and brain endure profound hypoxia, while the kidneys, viscera, and lower extremities receive hyperoxygenated ECMO blood.
• Monitoring Rule: Pulse oximetry placed on the lower extremity or even the left hand (which is distal to the left subclavian take-off and may receive retrograde ECMO flow) will show misleadingly normal saturations ($98\%\text{ to }100\%$).
• Mandatory Right Radial Arterial Line: Continuous arterial blood gas monitoring and pulse oximetry must be placed on the right upper extremity (right radial artery). The right radial artery branches from the brachiocephalic trunk; therefore, its blood reflects the exact oxygen tension delivered to the brain and coronary circulation.

Management & Circuit Escalation Strategies

When Harlequin syndrome is recognized (right radial $\text{PaO}_2 < 60\text{ mmHg}$ or $\text{SpO}_2 < 88\%$):

1. Ventilator Optimization: Increase mechanical ventilator $\text{FiO}_2$ to $1.0$, optimize PEEP to recruit collapsed alveoli, and perform gentle recruitment maneuvers. If the lungs can partially oxygenate blood, the native LV will eject oxygenated blood, abolishing differential hypoxemia.
2. Increase ECMO Pump Flow: Increasing pump revolutions per minute (RPM) elevates retrograde flow velocity, forcing the watershed collision zone further proximally toward the aortic valve. However, this raises LV afterload and can worsen LV dilation.
3. Conversion to Veno-Arterio-Venous (VAV) ECMO:
   • The Definitive Configuration: A Y-connector is spliced into the arterial reinfusion limb. A portion of the hyperoxygenated ECMO blood is diverted into a second venous cannula placed into the right internal jugular vein, with its tip in the right atrium or superior vena cava.
   • Mechanism: Oxygenated blood is delivered directly into the right heart, passing through the pulmonary circulation into the left heart. The native LV now ejects oxygenated blood into the aortic root, curing coronary and cerebral hypoxia while preserving systemic circulatory support.
4. Conversion to Central VA-ECMO: Re-cannulating the arterial return cannula directly into the ascending aorta via sternotomy ensures that all blood delivered to the aortic arch and coronary ostia is fully oxygenated.